Item Type No Grouping

Article

Editorial: Misuse and abuse of prescription drugs in custodial settings. (2023) Filippo Perani, Stefania Chiappini, Fabrizio Schifano and Arianna Giorgetti

Exploring the Nexus of Binge Eating Disorder (BED), New Psychoactive Substances (NPS), and Misuse of Pharmaceuticals: Charting a Path Forward. (2023) Stefania Chiappini, G. Duccio Papanti Pelletier, Rachel Vickers-Smith, John Corkery, Amira Guirguis, Giovanni Martinotti and Fabrizio Schifano

Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study. (2023) Stefania Chiappini and Giovanni Martinotti

An update on psychoactive substances: Pharmacology and Toxicology issues. (2023) Stefania Chiappini and Fabrizio Schifano

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. (2023) Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano

Investigating the effectiveness and tolerability of intranasal esketamine among older adults with treatment-resistant depression (TRD): a post-hoc analysis from the REAL-ESK study group. (2023) Giacomo d’Andre, Roger S. McIntyre, Stefania Chiappini, Giulia Stefanelli, Rosalba Carullo, Ileana Andriola, Raffaella Zanardi, Vassillis Martiadis, Stefano L. Sensi, Gabriele Sani, Massimo Clerici, Giorgio Di Lorenzo, Antonio Vita, Mauro Pettorruso and Giovanni Martinotti

Ibogaine/Noribogaine in the treatment of Substance Use Disorders: a systematic review of the current literature. (2023) Alessio Mosca, Stefania Chiappini, Andrea Miuli, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, John Corkery, Carlos Canessa, Giovanni Martinotti and Massimo Di Giannantonio

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression. (2023) the REAL‐ESK Study Group, Giovanni Martinotti, Bernardo Dell'Osso, Giorgio Di Lorenzo, Giuseppe Maina, Alessandro Bertolino, Massimo Clerici, Stefano Barlati, Gianluca Rosso, Marco Di Nicola, Matteo Marcatili, Giacomo d'Andrea, Clara Cavallotto, Stefania Chiappini, Sergio De Filippis, Giuseppe Nicolò, Pasquale De Fazio, Ileana Andriola, Raffaella Zanardi, Domenica Nucifora, Stefania Di Mauro, Roberta Bassetti, Mauro Pettorruso, Roger S. McIntyre, Stefano L. Sensi, Massimo di Giannantonio, Antonio Vita, Giulia Baldacci, Sandro Belletti, Antonello Bellomo, Beatrice Benatti, Matteo Carminati, Rosalba Carullo, Domenico de Berardis, Renato de Filippis, Roberto Delle Chiaie, Francesco di Carlo, Gilberto Di Petta, Alessandro Galluzzo, Valentina Giorgelli, Ginevra Lombardozzi, Vassilis Martiadis, Chiara Mattei, Alessio Mosca, Cinzia Niolu, Miriam Olivola, Mauro Percudani, Maria Pepe, Eros Rossi, Maria Ilaria Scardigli and Filippo Tatì

Alprazolam-related deaths in Scotland, 2004-2020. (2022) John Martin Corkery, Amira Guirguis, Stefania Chiappini, Giovanni Martinotti and Fabrizio Schifano

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). (2022) Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Daniel R. Harris and Fabrizio Schifano

Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases. (2022) Nicolo Schifano, Paolo Cappogrosso, Luca Boeri, Guiseppe Fallara, Stefania Chiappini, Matthew Rewhorn, Omer Onur Cakir, Hannah Harvey, Fabio Castiglione, Hussain Alnajjar, Asif Muneer, Frederico Deho, Fabrizio Schifano, Francesco Montorsi and Andrea Salonia

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. (2022) Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti and Fabrizio Schifano

Brexpiprazole as a new approach of treatment in somatization disorder. (2022) Stefania Chiappini, Alessio Mosca, Giovanni Martinotti, Francesco Di Carlo, Andrea Miuli, Luigi Dattoli, Mauro Pettorruso and Massimo Di Giannantonio

Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms. (2021) Valerio Ricci, Giovanni Martinotti, Franca Ceci, Stefania Chiappini, Francesco Di Carlo, Julius Burkauskas, Ottavia Susini, Debora Luciani, Diego Quattrone, Domenico De Berardis, Mauro Pettorruso, Giuseppe Maina and Massimo Di Giannantonio

Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History. (2021) Giovanni Martinotti, Cristina Merino Del Villar, Andrés Garcia Cordoba, Lluís Andrés Tubau, Ivan Castro Sánchez, Francesco Di Carlo, Stefania Chiappini, Mauro Pettorruso, Fabrizio Schifano and Massimo Di Giannantonio

Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. (2021) Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, Alessio Mosca, Andrea Miuli, Francesco Di Carlo, Giacomo D’Andrea, Roberta Collevecchio, Ilenia Di Muzio, Stefano L. Sensi and Massimo Di Giannantonio

Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction. (2021) Stefania Chiappini, Fabrizio Schifano and Giovanni Martinotti

Beyond the Purple Drank. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports. (2021) Stefania Chiappini, Fabrizio Schifano, John Martin Corkery and Amira Guirguis

Misuse of prescription and over-the-counter drugs to obtain illicit highs: how pharmacists can prevent abuse. (2020) Stefania Chiappini, Amira Guirguis, John Corkery and Fabrizio Schifano

What about “Pharming”? Issues Regarding the Misuse of Prescription and Over‐the‐Counter Drugs. (2020) Stefania Chiappini and Fabrizio Schifano

Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports. (2020) Nicolo Schifano, Stefania Chiappini, Fabio Castiglione, Andrea Salonia and Fabrizio Schifano

Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports. (2020) Nicolo Schifano, Stefania Chiappini, Fabio Castiglione, Andrea Salonia and Fabrizio Schifano

COVID-19: The hidden impact on mental health and drug addiction. (2020) Stefania Chiappini, Amira Guirguis, Ann John, John Corkery and Fabrizio Schifano

An Insight into Z-Drug Abuse and Dependence : An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. (2019) Fabrizio Schifano, Stefania Chiappini, John Martin Corkery and Amira Guirguis

A Decade of Gabapentinoid Misuse: : An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database. (2016) Stefania Chiappini and Fabrizio Schifano

Thesis

Assessing the Extent and Characteristics of Non-medical Use of a Range of Prescribed Drugs: Epidemiological and Pharmacovigilance Approaches. (2022) Stefania Chiappini

Other

Piperazine Abuse and Psychosis: A Systematic Review of the Literature. (2024) Alessio Mosca, Stefania Chiappini, Andrea Miuli, Gianluca Mancusi, Clara Cavallotto, John Martin Corkery, Livia Miotti, Mauro Pettorruso, Giovanni Martinotti and Fabrizio Schifano

New trends of drug abuse in custodial settings: a systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances. (2024) Stefania Chiappini, Giorgia Vaccaro, Alessio Mosca, Andrea Miuli, Gianfranco Stigliano, Giulia Stefanelli, Giulia Giovannetti, Rosalba Carullo, Giacomo d'Andrea, Francesco Di Carlo, Clara Cavallotto, Mauro Pettorruso, Gilberto Di Petta, John Martin Corkery, Amira Guirguis, Jacqueline L. Stair, Giovanni Martinotti, Seena Fazel and Fabrizio Schifano

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18 F-FDG PET/CT Case Report. (2024) Maria Pepe, Marco Di Nicola, Fabrizio Cocciolillo, Stefania Chiappini, Giovanni Martinotti, Maria Lucia Calcagni and Gabriele Sani

Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels’ Decline: A Narrative Review. (2022) Nicolò Schifano, Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Mauro Pettorruso, Paolo Capogrosso, Federico Dehò, Giovanni Martinotti and Fabrizio Schifano

Misuse of anticholinergic medications: a systematic review. (2022) Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Semeraro, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Fabrizio Schifano and Massimo di Giannantonio

New Psychoactive Substances and suicidality: a systematic review of the current literature. (2021) Stefania Chiappini, Alessio Mosca, A. Miuli, Monica Chiara Santovito, Laura Orsolini, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Giovanni Martinotti, Massimo di Giannantonio and Fabrizio Schifano

Focus on over-the-counter drugs’ misuse; a systematic review on antihistamines, cough medicines and decongestants. (2021) Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, Monica Chiara Santovito, Alessio Mosca, Maria Chiara Santovito, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Massimo di Giannantonio and Giovanni Martinotti

Focus on over-the-counter drugs’ misuse; a systematic review on antihistamines, cough medicines and decongestants. (2021) Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, Monica Chiara Santovito, Alessio Mosca, Maria Chiara Santovito, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Massimo di Giannantonio and Giovanni Martinotti

Focus on over-the-counter drugs’ misuse; a systematic review on antihistamines, cough medicines and decongestants. (2021) Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, Monica Chiara Santovito, Alessio Mosca, Maria Chiara Santovito, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Massimo di Giannantonio and Giovanni Martinotti

Cannabidiol (CBD) Use in Psychiatric Disorders; A Systematic Review. (2019) Stefania Bonaccorso, Angelo Ricciardi, Caroline Zangani, Stefania Chiappini and Fabrizio Schifano

Use of Medicinal Cannabis and Synthetic Cannabinoids in Posttraumatic Stress Disorder (PTSD): a systematic review. (2019) Laura Orsolini, Stefania Chiappini, Umberto Volpe, Domenico De Berardis, Roberto Latini, Gabriele Duccio Papanti and John Corkery

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. (2018) Fabrizio Schifano, Stefania Chiappini, John Corkery and Amira Guirguis

Is There a Potential of Misuse for Quetiapine? (2018) Stefania Chiappini and Fabrizio Schifano